Globavir Biosciences, Inc., a biotechnology company developing diagnostic and therapeutic technologies to treat infectious diseases, has announced a partnership with BioManguinhos, a division of the Oswaldo Cruz Foundation, for a joint evaluation of Globavir's PanGlob RT-PCR Dengue diagnostic assay.
from The Medical News http://ift.tt/1FtnFQ2
from The Medical News http://ift.tt/1FtnFQ2
No comments:
Post a Comment